Share Name Share Symbol Market Type Share ISIN Share Description
Sinclair Pharma LSE:SPH London Ordinary Share GB0033856740 ORD 1P
  Price Change % Change Share Price Shares Traded Last Trade
  +0.05p +0.16% 31.10p 3,148,640 16:35:21
Bid Price Offer Price High Price Low Price Open Price
31.00p 31.10p 31.20p 31.00p 31.20p
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 45.30 -4.34 -0.01 156.7

Sinclair Pharma (SPH) Latest News (6)

More Sinclair Pharma News
Sinclair Pharma Takeover Rumours

Sinclair Pharma (SPH) Share Charts

1 Year Sinclair Pharma Chart

1 Year Sinclair Pharma Chart

1 Month Sinclair Pharma Chart

1 Month Sinclair Pharma Chart

Intraday Sinclair Pharma Chart

Intraday Sinclair Pharma Chart

Sinclair Pharma (SPH) Discussions and Chat

Sinclair Pharma Forums and Chat

Date Time Title Posts
21/9/201808:53Sinclair Pharma Thread2,014
15/10/201415:32TipTV: Sinclair Pharmaceuticals to head back towards 30p!-
21/2/200508:49Small cap Sinclair Pharma - Walmart inc.-

Add a New Thread

Sinclair Pharma (SPH) Most Recent Trades

No Trades
Trade Time Trade Price Trade Size Trade Value Trade Type
View all Sinclair Pharma trades in real-time

Sinclair Pharma (SPH) Top Chat Posts

Sinclair Pharma Daily Update: Sinclair Pharma is listed in the Pharmaceuticals & Biotechnology sector of the London Stock Exchange with ticker SPH. The last closing price for Sinclair Pharma was 31.05p.
Sinclair Pharma has a 4 week average price of 19.80p and a 12 week average price of 18.15p.
The 1 year high share price is 31.20p while the 1 year low share price is currently 14.45p.
There are currently 503,768,952 shares in issue and the average daily traded volume is 15,291,648 shares. The market capitalisation of Sinclair Pharma is £156,672,144.07.
steeplejack: Well that's good.Yet as a holder of many years,I find it strange that the shares halved in the six months prior to the bid.They fell from near the offer price only to a return to that level on the bid RNS.If I didn't know better I'd say that something untoward was occurring ahead of this bid with a falling share price helping to softening up long suffering shareholders.The management are the real beneficiaries here.
steeplejack: It's not possible to discover what the likes of Fidelity paid for their stock.I ended up with Sinclair as a consequence of the latter taking over Maelor years back.I remember that the share price then was around the low 30s.Sinclair were trading around 30p five years ago and barring a brief flurry up to the high 40s (when Tosca appeared to put the group into play) the shares have averaged around that 30ish level for yonks.The recent collapse to down to the mid teens is pretty odd all things considered ,making an approach of 32p look acceptable,on paper at least.All shareholders have had a torrid time with this perennial underperformer and I can't see how any of those larger institutions have made money here.Clearly,the opportunity cost loss is sizeable.At the end of the day,this is just another example of the rather pitiful world of AIM investment.Sadly,I expect Fidelity,Schroders etc ,to throw in the towel like Tosca and cmpany
chozza: Bid touted at 32p. About half of what I need to break even. Interesting views on Tosca, will they be happy at 32p or like me underwater? This mornings share price movement would seem to indicate either a belief that the deal will be done or a belated recognition that SPH is seriously undervalued. Cheers, Chozza (Still standing survivor of the recent iii train wreck)
steeplejack: Very true,Tosca won’t want to sell out at a loss. The Chinese must of been aware from the very beginning that the agreement of Tosca was a prerequisite of a successful bid.Remember this statement made in early July- “HMC is a leading Chinese pharmaceutical manufacturer and distributor, and is also one of the largest aesthetic marketing companies in China offering botulinum toxin products and fillers. The company's strategy is to become one of the leading aesthetic companies worldwide and believes that Sinclair would support HMC in achieving this ambition. There can be no certainty that an offer will be made, nor as to the terms on which any offer might be made though HMC and CGE confirm that any offer is likely to be solely in cash.” So if the bid is likely to be made in cash,why is the share price going down?Frankly I can’t see our esteemed shareholder list accepting 20p.Maybe the terms of any bid have subtly altered during discussions such that the Chinese might take a controlling interest but the existing major shareholders keep ‘skin’ in the game.The share price is saying that no bid will occur but the extensions of PUSU suggest otherwise.It’s opaque.
+eysenck: 2 days to and all is quiet. Share price movements are not preceding the news on this occasion.
dealit: "Mercer95, egg", since July 6th their as been 13 8.5 announcements and the share price as moved up and back down again, please tell me why??
steeplejack: Strikes me as a surly response to an ok set of results.It is of course likely that this share is rather badly researched and that share price reactions are mercurial.The trouble is the,the prospective PE rating has always been fairly generous.The company will have to put more meat on the bones as to why its decided to go it it alone on the distribution front.I don't have enough experience to know how radical a decision this is,but I suspect it might be a good deal more demanding than immediately seems apparent.
steeplejack: All very encouraging..........what it irritates me is "the mystery" surrounding this persistent and relentless fall in price from the mid 30s.Have we been misled,has a wheel unexpectedly fallen off the wagon,has management exaggerated product prospects.Something's amiss and Monday will either confirm the reason for the share price slide or show it to be erroneous.Sadly,experience tells me to expect the former.
soundbuy: Hmmmm........remember the day SPH sold assets to APH......many thought APH had well over-paid, share price reacted badly and it looked as if SPH had pulled a blinder.......move on a couple of years and SPH languishing in the doldrums, burning through the proceeds with APH on the ascent, sweating those very same assets......
dealit: Encouraging share price rise today, maybe announcement on new distribution partnership is reason why share price has moved North today. IMHO the share price will slowly go upwards in anticipation of result statement next month.
Sinclair Pharma share price data is direct from the London Stock Exchange
add chat code
Your Recent History
Gulf Keyst..
FTSE 100
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:43 V: D:20180923 17:46:01